GRCh37/hg19 4q31.22-31.23(chr4:148378902-148750802) AND not specified

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Mar 1, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002053461.3

Allele description [Variation Report for GRCh37/hg19 4q31.22-31.23(chr4:148378902-148750802)]

GRCh37/hg19 4q31.22-31.23(chr4:148378902-148750802)

Genes:: ARHGAP10:Rho GTPase activating protein 10 [Gene - OMIM - HGNC]
EDNRA:endothelin receptor type A [Gene - OMIM - HGNC]
PRMT9:protein arginine methyltransferase 9 [Gene - OMIM - HGNC]
TMEM184C:transmembrane protein 184C [Gene - OMIM - HGNC]
Variant type:: copy number gain
Cytogenetic location:: 4q31.22-31.23
Genomic location:: Chr4: 148378902 - 148750802 (on Assembly GRCh37)
Preferred name:: GRCh37/hg19 4q31.22-31.23(chr4:148378902-148750802)
Observations:: 1

Condition(s)

Synonyms:: AllHighlyPenetrant
Identifiers:: MedGen: CN169374

Recent activity

Clear Turn Off Turn On

E3 ubiquitin-protein ligase parkin isoform X9 [Mus musculus]
E3 ubiquitin-protein ligase parkin isoform X9 [Mus musculus]
gi|1039753958|ref|XP_017173065.1|

Protein
PREDICTED: Mus musculus transmembrane protein with EGF-like and two follistatin-...
PREDICTED: Mus musculus transmembrane protein with EGF-like and two follistatin-like domains 2 (Tmeff2), transcript variant X2, mRNA
gi|1907069851|ref|XM_036152485.1|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002320257	ARUP Laboratories, Cytogenetics and Genomic Microarray, ARUP Laboratories	criteria provided, single submitter (ARUP Cytogenomic Constitutional CNV Assertion Criteria)	Uncertain significance (Mar 1, 2022)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002320257

ARUP Laboratories, Cytogenetics and Genomic Microarray, ARUP Laboratories

criteria provided, single submitter

(ARUP Cytogenomic Constitutional CNV Assertion Criteria)

Uncertain significance
(Mar 1, 2022)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	1	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From ARUP Laboratories, Cytogenetics and Genomic Microarray, ARUP Laboratories, SCV002320257.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	1	not provided	not provided	clinical testing	not provided

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		1	not provided	not provided	not provided

Last Updated: Aug 15, 2022

ClinVar

Relating variation to medicine